Taiwan named its new marine research vessel the New Ocean Researcher 1, built at a cost of approximately $50 million. It is an ocean-class multi-functional ocean research vessel and Taiwan’s largest ocean research ship. The ship is the third new research vessel launched by Taiwan to
Tritec Marine and Stena LNG are collaborated to create an innovative "SAFE Bunker" concept.
Of the few positive outcomes of the pandemic, the most significant must be the acceleration effect it has applied to the use of new technology. Beyond the obvious growth in video conferencing and e-commerce, it has spurred interest in applications from digital payments and telemedicine to process au
A broad range of initiatives is continuing to work on developing new sources of fuel for the maritime industry. In Japan, a group led by NYK Line announced efforts to speed the commercialization of ammonia while in China a new research partnership is being launched by China Merchants and the Italian
Summary: Responsible to perform electrical work as assigned by the Chief Electrician. Description: Accepting applications for Summer Shipyard in Canary Islands and Fall Field Service in Africa. apply.mercyships.org
Norway is taking the helm to develop technology that will be used to send unmanned vessels to sea on assignments without a crew on board.
The Emergency Prevention, Preparedness and Response (EPPR) Working Group of the Arctic Council has released a Guideline for Arctic Marine Risk Assessment.
Norwegian ship-owner Ocean Yield ASA has taken delivery of two Ultramax dry bulk vessels purchased from Monaco-based Scorpio Bulkers.
Scottish offshore vessel operator North Star Shipping has secured a $375 million contract to build and operate three service operation vessels (SOVs) for the Dogger Bank Wind Farm, the world's largest offshore wind project. North Star is a newcomer to offshore wind, and it won the contract
ASTRAZENECA FINDS NO EVIDENCE OF INCREASED BLOOD CLOT RISK FROM VACCINE AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots. AstraZeneca's review, which cover